Clinical trial

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women…

NCT00082979 · Royal Marsden NHS Foundation Trust, Other · Unknown status

Key facts

NCT number NCT00082979
Title Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
Official title Evaluation of the Role of Duct Endoscopy in the Assessment of Cellular Atypia Within Breast Duct Fluid in High-Risk Women Carrying BRCA1/2 or p53 Gene Mutations
Lead sponsor Royal Marsden NHS Foundation Trust, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Breast Cancer
Intervention type Genetic, Other, Procedure
Interventions cytogenetic analysis, proteomic profiling, cytology specimen collection procedure, immunohistochemistry staining method, laboratory biomarker analysis, breast duct lavage
Enrollment 60
Start date Oct 1, 2003
First posted May 17, 2004
Last update posted Aug 26, 2013
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies